- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2625EUR$2,750USD£2,199GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
The Pseudomonas Test market is a segment of the Infectious Disease Testing industry that focuses on the detection of Pseudomonas bacteria. This bacteria is a common cause of infection in humans, and can cause a range of illnesses, from mild to severe. Tests for Pseudomonas are used to diagnose and monitor the progression of the infection, as well as to determine the best course of treatment. Tests are available in a variety of formats, including culture, PCR, and antigen detection.
The Pseudomonas Test market is highly competitive, with a number of companies offering products and services. These include Abbott, Becton Dickinson, Bio-Rad, Cepheid, DiaSorin, Hologic, Luminex, Quidel, Roche, and Thermo Fisher Scientific. Show Less Read more